Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti cancer efficacy of the drug
 
Yazarlar (6)
Gözde Ünsoy Middle East Technical University, Türkiye
Pelin Mutlu Orta Doğu Teknik Üniversitesi, Türkiye
Prof. Dr. Serap YALÇIN AZARKAN Kırşehir Ahi Evran Üniversitesi, Türkiye
Ayşen Tezcaner Middle East Technical University, Türkiye
Ufuk Gündüz Orta Doğu Teknik Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı EUROPEAN JOURNAL OF PHARMACOLOGY
Dergi ISSN 0014-2999 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 08-2016
Kabul Tarihi 12-04-2026 Yayınlanma Tarihi
Cilt / Sayı / Sayfa 784 / 0 / 121–128 DOI 10.1016/j.ejphar.2016.05.016
Makale Linki http://linkinghub.elsevier.com/retrieve/pii/S0014299916303193
Özet
Targeted delivery of anti-cancer drugs increase the efficacy, while decreasing adverse effects. Among various delivery systems, chitosan coated iron oxide nanoparticles (CsMNPs) gained attention with their biocompatibility, biodegradability, low toxicity and targetability under magnetic field. This study aimed to increase the cellular uptake and efficacy of Gemcitabine.CsMNPs were synthesized by in situ co-precipitation and Gemcitabine was loaded onto the nanoparticles. Nanoparticle characterization was performed by TEM, FTIR, XPS, and zeta potential. Gemcitabine release and stability was analyzed. The cellular uptake was shown. Cytotoxicity of free-Gemcitabine and Gem-CsMNPs were examined on SKBR and MCF-7 breast cancer cells by XTT assay.Gemcitabine loading was optimized as 30 µM by spectrophotometric analyses. Drug release was highest (65%) at pH 4.2, while it was 8% at pH 7.2. This is a …
Anahtar Kelimeler
Chitosan | Magnetic nanoparticles | Gemcitabine | Targeted drug delivery | Breast cancer
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Google Scholar 128
Web of Science 89
Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti cancer efficacy of the drug

Paylaş